SCHEMBL25545936

SCHEMBL25545936

COc1cc(-c2nc(Cl)sc2CC(C)(C)C)ccc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAX8 Q06710 1/20 0.39
LMNA P02545 2/20 0.38
MAPT P10636 1/20 0.38
ABCC1 P33527 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
ALDH1A1 P00352 4/20 0.35
KDM1A O60341 1/20 0.35
GRK6 P43250 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PIK3CD O00329 1/20 0.34
ABL1 P00519 1/20 0.34
EGFR P00533 1/20 0.34
HCK P08631 1/20 0.34
SRC P12931 1/20 0.34
KDR P35968 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CG P48736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25546017 0.88 ALDH1A1 (0.37) LMNAMAPTALDH1A1KMT2AGRM2
SCHEMBL25556500 0.88 LMNA (0.38) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL25546067 0.88 RIPK2 (0.41) LMNAMAPTALDH1A1GRM2KDM4E
SCHEMBL25546218 0.85 GRM2 (0.43) ALDH1A1SRCGAAGRM2
SCHEMBL25545928 0.83 FBP1 (0.42) PAX8LMNAMAPTABCC1ABCG2
SCHEMBL25545935 0.81 PAX8 (0.38) PAX8LMNAMAPTALDH1A1GRK6
SCHEMBL25545980 0.81 ALDH1A1 (0.36) ALDH1A1EGFRPTGS2MAPK1KDM4E
SCHEMBL25556325 0.79 LMNA (0.32) LMNAMAPTGRM2
SCHEMBL25556504 0.79 ALDH1A1 (0.37) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL25180286 0.78 GRM2 (0.41) LMNAMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 PAX8 2117/4885LMNA 2647/4885MAPT 2231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.